Melanotan II
A more potent, less selective alpha-MSH analog with additional effects on appetite and libido alongside pigmentation.
Research status: Not FDA-approved; used in research settings only.
This page is a research-orientation summary, not a dosing guide. For anything beyond general background, read the primary literature or talk to a qualified clinician — specifics like amount, frequency, or administration aren't something we publish here.
Selected references
- British Journal of Dermatology · 2006 A randomized controlled trial of melanotan II in the induction of eumelanin synthesis in fair-skinned subjects
- Urology · 1998 Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study
- Life Sciences · 1996 Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study
- Peptides · 2006 Discovery and development of novel melanogenic drugs: Melanotan-I and -II
Curated from published literature for research orientation. Not an exhaustive review, and not a substitute for reading primary sources.
Related in Tanning